SL Science Holding Limited (SLBT), a biomedical company, on Thursday announced filing a new Master Drug File (MDF) with the U.S. Food and Drug Administration (FDA) to cover exosomes derived from Gamma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results